Delivery Order SPE2DB25D3008-SPE2DB25FRCTD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,216.50, is non-competitive and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The award represents a single pharmaceutical product delivery under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,001.00, is scheduled for completion by June 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the company's competitive...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for NEXLIZET 180-10 MG tablets in 30-count units, valued at $2,205.61. This firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office division. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Nexlizet 180-10 mg tablets in packages of 30 units, with a contract ceiling value of $3,192.92. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 4, 2025. This delivery...
- The Defense Logistics Agency awarded a $1,250.17 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Nexletol 180 mg on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Nexletol 180 mg tablets (30-unit packaging) valued at $1,389.23. This competitively awarded, firm fixed-price delivery order is non-set-aside and has a completion date of July 31, 2025. The award is issued to AmerisourceBergen Drug Corp's Corporate Office, with performance taking place at the company's Conshohocken, Pennsylvania headquarters, which serves as a major hub for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Nexletol 180 mg tablets (30-count units) with a contract ceiling value of $1,216.14. This firm fixed-price delivery order, which carries an ultimate completion date of June 6, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a $12,449.18 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Lazcluze 80 mg, with performance at the company's headquarters in Conshohocken, Pennsylvania, and completion targeted for September 30, 2025. This non-set-aside contract was competitively awarded on September 9, 2025, under firm fixed pricing terms and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $1,162.98 to AmerisourceBergen Drug Corp for NEXLETOL 180 mg tablets (30-count units) on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NEXLETOL is a non-statin, non-ezetimibe medication used to manage cholesterol levels in patients with...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $10,447.93 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The work will be performed at the company's corporate office location in Conshohocken,...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRCTDDelivery Order
The Defense Logistics Agency awarded a $1,487.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nexlizet 180-10 mg tablets in quantities of 30, with an ultimate completion date of July 28, 2025. This non-competitive, non-set-aside delivery order was issued on July 25, 2025, and represents a routine pharmaceutical supply transaction to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a comprehensive global pharmaceutical support vehicle, the IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's established position as a major pharmaceutical distributor and the firm fixed-price delivery order structure demonstrate the company's capability to fulfill federal medical supply requirements efficiently through its existing contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/25/25 |